Onco-Innovations Limited (CVE:ONCO) | WebDisclosure

Basculer en Français

10855	Companies
235911	Keywords
164859	Articles
126469	Press releases

Headlines Articles Press releases Onco-Innovations Limited

Home
Companies
Onco-Innovations Limited

PRESS RELEASE

published on 06/14/2025 at 00:00, 1 year 2 months ago

Onco-Innovations Engages the University of Alberta and Cross Cancer Institute to Expand PNKP Inhibitor Research into Hard-to-Treat Cancers
Onco-Innovations partners with University of Alberta and Cross Cancer Institute for preclinical study focusing on hard-to-treat cancers, starting with glioblastoma. Research led by Dr. Michael Weinfeld

Preclinical Study Glioblastoma Onco-Innovations University Of Alberta Cross Cancer Institute
BRIEF

published on 06/06/2025 at 00:05, 1 year 2 months ago

Onco-Innovations Launches AI-Oncology Consortium

Personalized Cancer Care Predictive Modeling AI In Oncology Multimodal Data Cross-Sector Collaboration
BRIEF

published on 06/06/2025 at 00:05, 1 year 2 months ago

Onco-Innovations lance un consortium IA-Oncologie

Collaboration Intersectorielle Modélisation Prédictive L'IA En Oncologie Données Multimodales Soins Personnalisés Contre Le Cancer
PRESS RELEASE

published on 06/06/2025 at 00:00, 1 year 2 months ago

Onco-Innovations' Inka Health to Launch Global AI-Oncology Consortium to Advance Predictive Cancer Research
Onco-Innovations Limited's subsidiary, Inka Health Corp., launches PROmAI Consortium for AI in oncology to enhance predictive modeling and collaboration among key stakeholders

Predictive Modeling Onco-Innovations Limited Inka Health Corp. AI In Oncology PROmAI Consortium
BRIEF

published on 05/27/2025 at 00:07, 1 year 2 months ago

Onco-Innovations Advances with Manufacturing for PNKP Inhibitor

Cancer Research Preclinical Testing Onco-Innovations PNKP Inhibitor Dalton Pharma
BRIEF

published on 05/27/2025 at 00:07, 1 year 2 months ago

Onco-Innovations progresse dans la fabrication d'un inhibiteur de la PNKP

Recherche Sur Le Cancer Onco-Innovations Dalton Pharma Inhibiteur De PNKP Tests Précliniques
PRESS RELEASE

published on 05/27/2025 at 00:02, 1 year 2 months ago

Onco-Innovations Announces Start of Manufacturing of Preclinical Testing Material for Its PNKP Inhibitor Technology by Dalton Pharma
Onco-Innovations announces commencement of manufacturing for preclinical testing of nanoparticle-formulated PNKP inhibitor technology in collaboration with Dalton Pharma Services

Manufacturing Preclinical Testing Onco-Innovations Dalton Pharma Services Nanoparticle
BRIEF

published on 05/26/2025 at 15:05, 1 year 2 months ago

Onco-Innovations Extends Marketing Partnership with MCS

Digital Advertising Cancer Research Marketing Partnership Onco-Innovations MCS GmbH
BRIEF

published on 05/26/2025 at 15:05, 1 year 2 months ago

Onco-Innovations étend son partenariat marketing avec MCS

Publicité Numérique Partenariat Marketing Recherche Sur Le Cancer Onco-Innovations MCS GmbH
PRESS RELEASE

published on 05/26/2025 at 15:00, 1 year 2 months ago

Onco-Innovations Extends Marketing Program
Onco-Innovations Limited extends engagement with MCS Market Communication Service GmbH for online marketing services until June 30, 2025. No securities provided as compensation

Digital Channels Onco-Innovations Limited MCS Market Communication Service GmbH Online Marketing Services Engagement Extension

Accesswire

Published on 08/20/2026 at 02:22, 6 hours 29 minutes ago

Infrastructure Sterilisation Drilling Begins at Tunkillia
Published on 08/20/2026 at 01:00, 7 hours 51 minutes ago

Irving Resources Announces Results of AGM
Published on 08/20/2026 at 00:40, 8 hours 11 minutes ago

Onco-Innovations Enters into LOI with Ifowonco for Exclusive Option and Worldwide Licence to LAG-3 Small-Molecule Inhibitor Program
Published on 08/19/2026 at 22:00, 10 hours 51 minutes ago

Jaguar Health Reports Second Quarter 2026 Financials
Published on 08/19/2026 at 20:35, 12 hours 16 minutes ago

Revive Therapeutics Announces Proposed Shares for Debt Settlement

View all ACCESSWIRE

EQS Group

Published on 08/20/2026 at 08:30, 21 minutes ago

Suspension: JTC PLC
Published on 08/20/2026 at 08:15, 36 minutes ago

The Platform Group continues profitable growth in H1 2026 - organic growth strengthens profitability and cash flow
Published on 08/20/2026 at 08:00, 51 minutes ago

Genel Energy PLC: Notification of Proposed Transfer from the Equity Shares (Transition) Category to the Equity Shares (Commercial Companies) Category
Published on 08/20/2026 at 07:45, 1 hour 6 minutes ago

Mayr-Melnhof Karton AG: MM reports half-year results for 2026
Published on 08/20/2026 at 07:30, 1 hour 21 minutes ago

tonies extends lead in North America and increases global revenue by 41% in H1 2026 – exceptional demand for Toniebox 2 fuels strong growth dynamic

Les Echos

Published on 08/18/2026 at 18:00, 1 day 14 hours ago

KLARSEN : Nomonation Olivier Cornelis DG ITL et webinaire
Published on 08/18/2026 at 17:45, 1 day 15 hours ago

Mise à disposition du rapport financier annuel 2025-26
Published on 08/18/2026 at 11:15, 1 day 21 hours ago

GUILLEMOT CORPORATION | Déclaration hebdomadaire des transactions sur actions propres du 10 au 14 août 2026
Published on 08/18/2026 at 11:15, 1 day 21 hours ago

GUILLEMOT CORPORATION | Weekly report share buyback from August 10 to August 14 2026
Published on 08/17/2026 at 19:45, 2 days 13 hours ago

Aéroports de Paris S.A - July 2026 traffic figures

View all LES ECHOS COMFI WIRE